E-mail: radana.neuwirtova@lf1.cuni.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikované knihy
Publikovaná abstrakta
- Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes
- COMPLEX CHROMOSOMAL ABERRATIONS IN BONE MARROW CELLS OF 86 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
- CYTOPENIA PARTICULARLY THROMBOCYTOPENIA AT DIAGNOSIS AS AN IMPORTANT NEGATIVE PROGNOSTIC MARKER FOR PATIENTS WITH ISOLATED 5Q- ABNORMALITY AND NO BLASTS IN BONE MARROW
- DEFERASIROX REPRESENTS AN EFFECTIVE ORAL IRON CHELATOR IN LOW OR INTERMEDIATE-1 RISK PATIENTS WITH MDS – A COMPARATIVE STUDY TO THE TREATMENT WITH DEFERIPRONE
- EFFECT OF LENALIDOMIDE TREATMENT ON THE EXPRESSION OF FLI1, EKLF, TP53, HDM2, PU. 1 AND IL-6 GENES IN 5Q- SYNDROME
- EFFICIENCY AND SAFETY OF ADMINISTRATION OF ORAL IRON CHELATOR DEFERIPRONE IN PATIENTS WITH EARLY MYELODYSPLASTIC SYNDROME (MDS)
- EXPRESSION SIGNATURE OF GENES ASSOCIATED WITH TELOMERE-TELOMERASE COMPLEX IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE LEUKEMIA: TEP1 GENE IS SURPRISINGLY UPREGULATED IN PROGRESSION OF MDS AND IN LEUKEMIC CELLS
- Fli-1 and EKLF Gene Expression in Patients with MDS 5q- Syndrome
- Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q)
- Gene Expression Changes In Patients with 5q- Syndrome Treated with Lenalidomide
- High Cereblon Expression In Lower Risk Myelodysplastic Syndromes With 5q Deletion Is Associated With The Efficacy Of Lenalidomide
- HIGH LEVELS OF CEREBLON MESSENGER RNA ARE THE CHARACTERISTIC FEATURE OF LOWER RISK MYELODYSPLASTIC SYNDROMES WITH 5Q DELETION AND ARE CONNECTED WITH THE EFFICACY OF LENALIDOMIDE
- CHROMOTHRIPSIS IN BONE MARROW CELLS OF ADULT PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) WITH COMPLEX KARYOTYPES
- IMMUNOLOGICAL BACKGROUND OF MDS, AN IMPACT ON PROGNOSIS AND PATHOGENESIS OF MDS
- Lenalidomid (Revlimid) v léčbě mnohočetného myelomu – naše první zkušenosti
- Putative Monosomy 5 In Myelodysplastic Syndromes (MDS) Is Probably Resulting From Chromothripsis
- TELOMERASE ACTIVITY INCREASES IN PROGRESSION OF MYELODYSPLASTIC SYNDROMES AND IS COMMON FEATURE OF UNTREATED ACUTE MYELOID LEUKEMIA ASSOCIATED WITH A PORTION OF BLASTS IN ANALYZED TISSUE
- The Significance of Megakaryocytic Transcription Factor Fli1 and Erythroid Transcription Factor EKLF in the Ribosomopathies: 5q Minus Syndrome and Diamond-Blackfan Anemia. the Role of Fli1 in p53 Regulation and in 5q Minus Syndrome Megakaryopoiesis
- THE SIGNIFICANT ASSOCIATION BETWEEN PRIMARY MYELODYSPLASTIC SYNDROME AND SINGLE NUCLEOTIDE POLYMORPHISMS
- TRUE MONOSOMY OF CHROMOSOME 5 IS PRESUMABLY NOT AN ISOLATED CYTOGENETIC ENTITY IN MDS
- Vyšetřování buněk účastnících se v buňkami zprostředkované imunologické reakci u MDS. Možný význam nálezů pro patogenezu MDS.
